Press Releases from SPL medical BV (2 total)
Ferumoxtran, the iron-based investigational MRI contrast agent of SPL Medical B. …
Nijmegen, The Netherlands, 26.05.2025 - SPL Medical B.V. announced today further results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the…
Ferumoxtran, the iron-based investigational MRI contrast agent of SPL Medical B. …
Nijmegen, The Netherlands, 25.02.2025 - SPL Medical B.V. announced today the headline results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess…
Go To Page:
